Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

por Mahaweni, Niken M., Kaijen-Lambers, Margaretha E.H., Dekkers, Jacqueline, Aerts, Joachim G.J.V., Hegmans, Joost P.J.J.
Publicado 2013

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

por Veltman, Joris D., Lambers, Margaretha E. H., van Nimwegen, Menno, de Jong, Sanne, Hendriks, Rudi W., Hoogsteden, Henk C., Aerts, Joachim G. J. V., Hegmans, Joost P. J. J.
Publicado 2010

Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based i...

por Noordam, Lisanne, Kaijen, Margaretha E.H., Bezemer, Koen, Cornelissen, Robin, Maat, Lex A.P.W.M., Hoogsteden, Henk C., Aerts, Joachim G.J.V., Hendriks, Rudi W., Hegmans, Joost P.J.J, Vroman, Heleen
Publicado 2018